Nephrology Clinical Trial
Official title:
To Investigate the Protective Effect of AC 134 in Chronic Kidney Diseases.
The objective is to explore the effects of adding AC-134 on renal function, proteinuria, uremic toxins, and metabolism-related markers in chronic kidney disease.
Chronic kidney disease (CKD) management primarily focuses on addressing associated complications such as hypertension, diabetes mellitus, cardiovascular disease, and proteinuria. In addition to standard therapies, reducing the accumulation of toxins, particularly gut-derived uremic toxins like indoxyl sulfate (IS) and p-cresol sulfate (PCS), may help alleviate uremia symptoms. This study assesses the impact of oral AC-134 capsules containing activated charcoal adsorbent on CKD patients. The assessment will include evaluating changes in renal function, proteinuria, uremic toxins, and metabolism-related markers. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00379899 -
ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 4 | |
| Completed |
NCT00146224 -
Efficacy of Epoetin Alfa Deep Tank in Treatment of Anemia in Patients With Chronic Kidney Disease Receiving Hemodialysis
|
Phase 3 | |
| Recruiting |
NCT05991245 -
French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy"
|
||
| Completed |
NCT00189501 -
A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
|
N/A | |
| Completed |
NCT04122222 -
Immune Response to Influenza Vaccine in ESRD Patients
|
N/A |